WHO ICTRP trial
A study about the Optimization of Helicobacter pylori resistance level, CYP2C19…
ChiCTR-OOC-15005857 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-OOC-15005857 |
|---|---|
| Public title | A study about the Optimization of Helicobacter pylori resistance level, CYP2C19 polymorphism survey and eradication of Helicobacter pylori of rural population in Chongqing |
| Scientific title | A study about the Optimization of Helicobacter pylori resistance level, CYP2C19 polymorphism survey and eradication of Helicobacter pylori of rural population in Chongqing |
| Primary sponsor | Daping Hospital, the Third Military Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | Other |
| Countries | China |
| Conditions | diseases of upper digestive tract |
| Interventions | A:Nexium / rabeprazole + amoxicillin + furazolidone + bismuth;B:Omeprazole / lansoprazole / pantoprazole + amoxicillin + furazolidone + bismuth;C:Nexium / rabeprazole + amoxicillin + clarithromycin |
| Registration date | Jan 12, 2015 |
| Target size | A:50;B:50;C:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: